Top Health Care companies in United States by Return on Equity (ROE)

This ranking features the top 612 Health Care companies in United States ranked by Return on Equity (ROE), averaging a Return on Equity (ROE) of -143.72%, for January 15, 2025.

United States

Health Care

#	Name	Return on Equity (ROE)	Reported Date	Stock Price	Change	Country
1	Palatin Technologies, Inc. 1 PTN	1,933.03%	Dec. 31, 2023	USD 1.12	0.90%	United States
2	Insmed Incorporated 2 INSM	1,259.44%	Sept. 30, 2024	USD 68.29	-0.93%	United States
3	CAMP4 Therapeutics Corporation 3 CAMP	1,100.92%	Nov. 30, 2023	USD 3.74	-5.32%	United States
4	LifeMD, Inc. 4 LFMD	1,005.10%	Sept. 30, 2024	USD 4.73	0.21%	United States
5	Atara Biotherapeutics, Inc. 5 ATRA	965.52%	Sept. 30, 2024	USD 12.31	-23.96%	United States
6	Immuneering Corporation 6 IMRX	960.26%	Sept. 30, 2023	USD 1.95	-2.99%	United States
7	UroGen Pharma Ltd. 7 URGN	932.03%	Sept. 30, 2024	USD 9.93	-2.46%	United States
8	22nd Century Group, Inc. 8 XXII	912.03%	Sept. 30, 2024	USD 6.35	5.83%	United States
9	Organon & Co. 9 OGN	846.18%	Sept. 30, 2024	USD 15.81	0.96%	United States
10	BioSig Technologies, Inc. 10 BSGM	835.94%	Sept. 30, 2024	USD 1.29	-8.51%	United States
11	NeurAxis, Inc. 11 NRXS	416.04%	Sept. 30, 2024	USD 2.52	-0.79%	United States
12	Allarity Therapeutics, Inc. 12 ALLR	405.19%	March 31, 2024	USD 1.01	-5.61%	United States
13	Xeris Biopharma Holdings, Inc. 13 XERS	397.13%	Sept. 30, 2024	USD 3.20	-2.44%	United States
14	Amneal Pharmaceuticals, Inc. 14 AMRX	378.68%	Sept. 30, 2024	USD 7.85	1.68%	United States
15	Cytokinetics, Incorporated 15 CYTK	335.19%	Sept. 30, 2024	USD 45.23	-3.17%	United States
16	Alnylam Pharmaceuticals, Inc. 16 ALNY	323.66%	Sept. 30, 2024	USD 240.51	-6.88%	United States
17	TriSalus Life Sciences, Inc. 17 TLSI	284.08%	June 30, 2024	USD 4.69	-4.29%	United States
18	Plus Therapeutics, Inc. 18 PSTV	271.49%	Sept. 30, 2024	USD 1.17	2.63%	United States
19	Regional Health Properties, Inc. 19 RHE	265.81%	Sept. 30, 2024	USD 2.08	3.48%	United States
20	Phathom Pharmaceuticals, Inc. 20 PHAT	251.33%	June 30, 2024	USD 6.79	2.57%	United States
21	4D Molecular Therapeutics, Inc. 21 FDMT	244.11%	Sept. 30, 2023	USD 4.88	2.52%	United States
22	OneMedNet Corporation 22 ONMD	220.55%	Sept. 30, 2023	USD 1.02	-0.97%	United States
23	Calidi Biotherapeutics, Inc. 23 CLDI	208.29%	June 30, 2024	USD 0.89	-3.59%	United States
24	Tempus AI, Inc. 24 TEM	189.39%	Sept. 30, 2024	USD 31.83	-1.58%	United States
25	Foghorn Therapeutics Inc. 25 FHTX	167.93%	Sept. 30, 2024	USD 4.24	-2.97%	United States
26	Accelerate Diagnostics, Inc. 26 AXDX	165.71%	Sept. 30, 2024	USD 1.08	-4.42%	United States
27	Cencora 27 COR	162.71%	Sept. 30, 2024	USD 240.05	1.68%	United States
28	Halozyme Therapeutics, Inc. 28 HALO	156.40%	Sept. 30, 2024	USD 53.83	-0.57%	United States
29	Cartesian Therapeutics, Inc. 29 RNAC	148.90%	Sept. 30, 2024	USD 18.02	-1.69%	United States
30	Omeros Corporation 30 OMER	143.46%	Sept. 30, 2024	USD 8.59	-2.27%	United States
31	Revance Therapeutics, Inc. 31 RVNC	133.65%	Sept. 30, 2024	USD 3.29	NA	United States
32	Agenus Inc. 32 AGEN	131.89%	Sept. 30, 2024	USD 3.15	-0.32%	United States
33	Akebia Therapeutics, Inc. 33 AKBA	129.56%	Sept. 30, 2024	USD 1.89	1.07%	United States
34	Envoy Medical, Inc. 34 COCH	126.17%	Dec. 31, 2023	USD 1.40	-11.39%	United States
35	Elutia Inc. 35 ELUT	124.47%	Sept. 30, 2024	USD 2.92	-6.71%	United States
36	vTv Therapeutics Inc. 36 VTVT	112.68%	Sept. 30, 2023	USD 13.34	-0.82%	United States
37	DaVita Inc. 37 DVA	110.29%	Sept. 30, 2024	USD 162.00	3.15%	United States
38	Tenet Healthcare Corporation 38 THC	101.08%	Sept. 30, 2024	USD 127.63	-1.27%	United States
39	Daré Bioscience, Inc. 39 DARE	97.03%	Sept. 30, 2024	USD 3.34	0.30%	United States
40	NeueHealth, Inc. 40 NEUE	96.37%	Sept. 30, 2024	USD 7.37	0.96%	United States
41	Outlook Therapeutics, Inc. 41 OTLK	95.60%	Sept. 30, 2024	USD 2.16	-5.68%	United States
42	Armata Pharmaceuticals, Inc. 42 ARMP	89.12%	Sept. 30, 2024	USD 2.02	NA	United States
43	ImmunityBio, Inc. 43 IBRX	86.39%	Sept. 30, 2024	USD 2.32	-6.45%	United States
44	Cryo-Cell International, Inc. 44 CCEL	85.69%	Aug. 31, 2024	USD 7.40	2.07%	United States
45	Heron Therapeutics, Inc. 45 HRTX	76.79%	Sept. 30, 2024	USD 1.47	-4.54%	United States
46	Peloton Interactive, Inc. 46 PTON	75.36%	Sept. 30, 2024	USD 8.73	-2.57%	United States
47	Agios Pharmaceuticals, Inc. 47 AGIO	70.20%	Sept. 30, 2024	USD 33.32	-2.86%	United States
48	Amgen Inc. 48 AMGN	68.49%	Sept. 30, 2024	USD 267.10	-1.14%	United States
49	Champions Oncology, Inc. 49 CSBR	66.22%	Oct. 31, 2024	USD 9.67	5.45%	United States
50	AbbVie Inc. 50 ABBV	65.72%	Sept. 30, 2024	USD 175.55	-0.67%	United States

1 2 3 4 … 13

Frequently Asked Questions

Which Health Care company in United States has the highest Return on Equity (ROE) ?

The Health Care company in United States with the highest Return on Equity (ROE) is Palatin Technologies, Inc. (NYSE American: PTN) at 1,933.03%.
Which Health Care company in United States has the lowest Return on Equity (ROE) ?

The Health Care company in United States with the lowest Return on Equity (ROE) is Nuwellis, Inc. (NasdaqCM: NUWE) at -26,663.64%.

What are the top 10 Health Care companies in United States by Return on Equity (ROE) ?

The top 10 Health Care companies in United States by Return on Equity (ROE) are Palatin Technologies, Inc., Insmed Incorporated, CAMP4 Therapeutics Corporation, LifeMD, Inc., Atara Biotherapeutics, Inc., Immuneering Corporation, UroGen Pharma Ltd., 22nd Century Group, Inc., Organon & Co. and BioSig Technologies, Inc..
What are the bottom 10 Health Care companies in United States by Return on Equity (ROE) ?

The bottom 10 Health Care companies in United States by Return on Equity (ROE) are Nuwellis, Inc., Inovio Pharmaceuticals, Inc., Nutex Health, Inc., IMAC Holdings, Inc., Summit Therapeutics Inc., Guardant Health, Inc., 180 Life Sciences Corp., Humacyte, Inc., Clene Inc. and Curis, Inc..